Nena, Baculi L.

HRN: 24-61-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2024
CEFAZOLIN 1GM (VIAL)
04/08/2024
04/08/2024
IVT
2g
Once On Call To OR
G1P1 (1001) Myoma Uteri
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Skin & Soft TissueReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: